Chamath Palihapitiya · Aug 23, 09:29 PM UTC

Moderna's cancer vaccine with Keytruda delayed cancer recurrence or spread; shares closed 177% higher

“All 1,137 patients had advanced skin cancer removed by surgery first. Two-thirds then got the custom shot plus Keytruda, a widely used cancer drug, and a third got Keytruda alone. Patients who received Moderna’s custom treatment with Keytruda went longer without their cancer returning or spreading than patients who received Keytruda alone. Moderna shares closed Wednesday 177% higher , their largest one-day gain on record.”